Disease Research
News and analysis on disease research and diagnostics.
NeoGenomics, Adaptive Biotech Partner to Offer Combined Blood Cancer Testing
Doctors ordering NeoGenomics Compass test packages will have the option of including Adaptive's ClonoSeq minimal residual disease assay.
Grifols Secures $21M MJFF Grant to Search for Early Parkinson's Biomarkers
Grifols subsidiary Alkahest will lead a pilot study to track proteomic changes in patient plasma samples over a 10-year period.
Italian Liquid Biopsy Tech Firm Tethis Secures €15M Investment
Tethis received the funding from a private investment organization managed by the Italian Ministry of Enterprises and Made in Italy.
The acquisition of genetic testing firm Ambry will open up new markets for Tempus, which is looking beyond the oncology field.
Mirxes Gets $40M Financing From CBC Group's R-Bridge to Support Global Expansion
The company is developing blood-based microRNA tests for early cancer detection and screening, with its flagship assay, GastroClear, already approved as an IVD in Singapore.